Targeting activated mineralocorticoid receptor: Occam's razor revisited
- 1 September 2012
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 82 (6) , 619-620
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II–induced cardiac, renal, and vascular injuryKidney International, 2012
- Variable expression of 11β Hydroxysteroid dehydrogenase (11β-HSD) isoforms in vascular endothelial cellsSteroids, 2008
- Mineralocorticoid Receptor Activation and Oxidative StressHypertension, 2007
- Effect of Angiotensin II on Rat Renal Cortical 11β-Hydroxysteroid DehydrogenaseEndocrine, 2000
- Regulation of 11β-hydroxysteroid dehydrogenase type 2 by diuretics and the renin–angiotensin–aldosterone axisClinical Science, 1999
- Influence of Dietary Sodium on the Renal Isoforms of 11 -Hydroxysteroid DehydrogenaseExperimental Biology and Medicine, 1997
- Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captoprilThe Journal of Clinical Endocrinology & Metabolism, 1994
- Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid ReceptorScience, 1987
- Anticortisol Action of AldosteroneScience, 1955